Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice

作者：Xue Luan, Kamil Rahme, Zhongcheng Cong, Limei Wang, Yifang Zou, Yan He, Hao Yang, Justin D. Holmes, Caitríona M. O’Driscoll, Jianfeng Guo · 发表于：European Journal of Pharmaceutics and Biopharmaceutics · 年份：2019 · DOI：10.1016/j.ejpb.2019.02.013 · 被引用次数：58 · 研究领域：RNA Interference and Gene Delivery、Advanced biosensing and bioanalysis techniques、Dendrimers and Hyperbranched Polymers